ZANFRAMUNDO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 1.247
EU - Europa 975
AS - Asia 828
SA - Sud America 214
AF - Africa 25
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.294
Nazione #
US - Stati Uniti d'America 1.202
CN - Cina 281
IE - Irlanda 238
SG - Singapore 233
DE - Germania 200
BR - Brasile 174
RU - Federazione Russa 148
HK - Hong Kong 140
FI - Finlandia 119
VN - Vietnam 74
IT - Italia 73
AT - Austria 61
GB - Regno Unito 50
IN - India 37
CA - Canada 29
JP - Giappone 18
SE - Svezia 15
AR - Argentina 13
FR - Francia 12
PL - Polonia 11
BE - Belgio 10
EC - Ecuador 10
MX - Messico 10
ZA - Sudafrica 9
IQ - Iraq 8
BD - Bangladesh 7
ID - Indonesia 7
NL - Olanda 7
CO - Colombia 6
ES - Italia 5
MA - Marocco 5
EG - Egitto 4
MK - Macedonia 4
PY - Paraguay 4
SA - Arabia Saudita 4
TR - Turchia 4
UA - Ucraina 4
AU - Australia 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
LT - Lituania 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DK - Danimarca 2
GM - Gambi 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
MU - Mauritius 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 3.294
Città #
Dublin 230
Chandler 180
Dallas 148
Hong Kong 140
Munich 135
Ashburn 128
Beijing 102
Singapore 93
Helsinki 89
Los Angeles 72
Vienna 51
New York 45
Shanghai 40
Boardman 39
Ho Chi Minh City 30
São Paulo 30
Redondo Beach 26
Princeton 24
Lawrence 23
Moscow 23
Medford 22
Turku 22
Pavia 20
Pune 16
Tokyo 15
Wilmington 15
Nuremberg 13
Santa Clara 12
Hanoi 11
Falkenstein 10
Milan 10
Warsaw 10
Brussels 9
London 9
Montreal 9
Orem 9
Poplar 9
Seattle 9
Atlanta 8
Buffalo 8
Chicago 8
Stockholm 8
The Dalles 8
Boston 7
Columbus 7
Council Bluffs 7
Ann Arbor 6
Chennai 6
Düsseldorf 6
Haiphong 6
Houston 6
Johannesburg 6
Mexico City 6
Portsmouth 6
Quito 6
San Francisco 6
Zhengzhou 6
Baghdad 5
Brooklyn 5
Changsha 5
Denver 5
Guangzhou 5
Jyväskylä 5
Nanjing 5
Rio de Janeiro 5
Tianjin 5
Toronto 5
Curitiba 4
Manchester 4
Mumbai 4
Phoenix 4
Piscataway 4
San Jose 4
Santo André 4
Secaucus 4
Biên Hòa 3
Cairo 3
Dhaka 3
Fairfield 3
Hangzhou 3
Hyderabad 3
Lauterbourg 3
Minsk 3
Moncalieri 3
Newark 3
Norwalk 3
Potomac 3
Raleigh 3
Thái Nguyên 3
Vancouver 3
Xi'an 3
Almaty 2
Andover 2
Asunción 2
Bauru 2
Betim 2
Brasília 2
Bắc Ninh 2
Calgary 2
Caracas 2
Totale 2.153
Nome #
Ultrasonography in psoriatic arthritis: Which sites should we scan? 232
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 112
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 107
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 106
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 104
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 98
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 88
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 87
One year in review 2018: idiopathic inflammatory myopathies 84
A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome 83
Pulmonary nocardiosis in a patient affected by anti-MDA5-positive amyopathic dermatomyositis under immunosuppressive therapy 81
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 81
Defining anti-synthetase syndrome: a systematic literature review 79
Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis 76
Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case 76
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 75
Adhesive capsulitis after COVID-19 vaccine injection: a peculiar case treated with combined bursa distention and glenohumeral capsular hydrodilatation 73
Respiratory failure due to concomitant interstitial lung disease and diaphragmatic involvement in a patient with anti-MDA5 dermatomyositis: a case report 73
Idiopathic inflammatory myopathies: one year in review 2021 73
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 72
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 68
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 68
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al 68
Clinical evolution of antisynthetase syndrome after SARS-CoV2 infection: a 6-month follow-up analysis 66
Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis 65
Evaluation of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies Through Semiquantitative and Quantitative Analysis of Lung Computed Tomography 64
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 62
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 61
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 60
The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project 56
Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al 54
One year in review 2020: Idiopathic inflammatory myopathies 49
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis from the CLASS project 45
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 45
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study 44
Right atrial reservoir strain as an early predictor of pulmonary hypertension development in systemic sclerosis: a single-centre pilot study 44
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort 44
Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study 43
Telemedicine in rheumatology: a reliable approach beyond the pandemic 42
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay 41
Rare clinical manifestations in systemic lupus erythematosus: A review on frequency and clinical presentation 40
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 39
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 38
The Antisynthetase Syndrome" 36
Heterogeneity in nomenclature and abbreviation usage for anti-synthetase syndrome: a scoping review 35
Efficacy of anifrolumab as a first-line therapy for the treatment of thrombocytopenia in systemic lupus erythematosus: a case report 35
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 31
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 28
Issues in the classification of myositis patients: an ongoing process 26
Idiopathic inflammatory myopathies and COVID-19: an intriguing liaison? 24
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology 23
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 20
Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? 18
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 17
First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry 9
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry 6
The myositis landscape in clinical trials: 2025 and beyond 6
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 5
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 5
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry 5
Totale 3.395
Categoria #
all - tutte 16.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 5 1 2 6 0 4 0
2021/2022161 13 2 4 1 6 3 1 10 14 5 21 81
2022/2023595 52 70 14 60 38 40 3 32 256 2 17 11
2023/2024315 30 63 11 21 19 65 20 17 2 27 14 26
2024/20251.025 23 40 10 21 20 97 129 77 244 53 110 201
2025/20261.212 189 119 244 303 269 88 0 0 0 0 0 0
Totale 3.395